# Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain

> **NCT01433328** · PHASE4 · TERMINATED · sponsor: **Jewish General Hospital** · enrollment: 4 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Lidocaine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01433328
- **Lead sponsor:** Jewish General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-01
- **Primary completion:** 2012-03
- **Final completion:** 2012-04
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Safety considerations
- **Last updated:** 2023-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01433328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01433328, "Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01433328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*